A1AAO: N-[(1S)-1-{(3M)-3-{4-chloro-3-[(cyclopropanesulfonyl)amino]-1-(2,2-difluoroethyl)-1H-indazol-7-yl}-6-[3-(methanesulfonyl)-3-methylbut-1-yn-1-yl]pyridin-2-yl}-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-3-(difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide
A1AAO is a Ligand Of Interest in 8VC0 designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8VC0_A1AAO_A_301 | 51% | 24% | 0.128 | 0.929 | 1.6 | 1.52 | 6 | 9 | 0 | 0 | 100% | 1 |
| 8VC0_A1AAO_H_301 | 49% | 25% | 0.123 | 0.909 | 1.64 | 1.44 | 8 | 8 | 0 | 0 | 100% | 1 |
| 8VC0_A1AAO_D_301 | 47% | 23% | 0.12 | 0.895 | 1.63 | 1.54 | 7 | 10 | 0 | 0 | 100% | 1 |
| 8VC0_A1AAO_C_301 | 46% | 24% | 0.122 | 0.894 | 1.64 | 1.47 | 8 | 9 | 0 | 0 | 100% | 1 |
| 8VC0_A1AAO_I_301 | 45% | 25% | 0.128 | 0.896 | 1.62 | 1.48 | 8 | 8 | 0 | 0 | 100% | 1 |
| 8VC0_A1AAO_G_301 | 44% | 25% | 0.125 | 0.887 | 1.63 | 1.45 | 8 | 8 | 0 | 0 | 100% | 1 |
| 8VC0_A1AAO_F_301 | 42% | 24% | 0.14 | 0.905 | 1.61 | 1.51 | 8 | 8 | 0 | 0 | 100% | 1 |
| 8VC0_A1AAO_B_301 | 39% | 24% | 0.132 | 0.876 | 1.63 | 1.51 | 8 | 9 | 0 | 0 | 100% | 1 |
| 8VC0_A1AAO_J_301 | 34% | 24% | 0.146 | 0.875 | 1.64 | 1.48 | 8 | 8 | 1 | 0 | 100% | 1 |
| 8VC0_A1AAO_E_301 | 31% | 24% | 0.146 | 0.86 | 1.63 | 1.49 | 7 | 8 | 0 | 0 | 100% | 1 |
